Nika Pharmaceuticals annual current ratio
2021
2022
2023
2024
2025
Nika Pharmaceuticals Current Ratio Growth & History (NIKA)
Nika Pharmaceuticals's current ratio was 0.07 for fiscal 2025.
View full Nika Pharmaceuticals company overviewNika Pharmaceuticals annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.07 | −0.01 | −12.12% |
| 2024 | 2024-12-31 | 0.07 | −0.12 | −61.07% |
| 2023 | 2023-12-31 | 0.19 | 0.15 | +305.26% |
| 2022 | 2022-12-31 | 0.05 | 0.01 | +25.28% |
| 2021 | 2021-12-31 | 0.04 | — | — |
Nika Pharmaceuticals quarterly current ratio
Q4.21
Q2.22
Q3.22
Q4.22
Q1.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.03 | −0.08 | −73.76% |
| Q1 2026 | 2026-03-31 | 0.06 | −0.07 | −52.13% |
| Q4 2025 | 2025-12-31 | 0.07 | −0.01 | −12.12% |
| Q3 2025 | 2025-09-30 | 0.08 | 0.08 | +1160.66% |
| Q2 2025 | 2025-06-30 | 0.11 | −0.24 | −68.10% |
| Q1 2025 | 2025-03-31 | 0.13 | −0.03 | −16.64% |
| Q4 2024 | 2024-12-31 | 0.07 | −0.12 | −61.07% |
| Q3 2024 | 2024-09-30 | 0.01 | −0.12 | −94.82% |
| Q2 2024 | 2024-06-30 | 0.35 | — | — |
| Q1 2024 | 2024-03-31 | 0.16 | 0.05 | +44.59% |
| Q4 2023 | 2023-12-31 | 0.19 | 0.15 | +305.26% |
| Q3 2023 | 2023-09-30 | 0.13 | −0.51 | −79.91% |
| Q1 2023 | 2023-03-31 | 0.11 | — | — |
| Q4 2022 | 2022-12-31 | 0.05 | 0.01 | +25.28% |
| Q3 2022 | 2022-09-30 | 0.63 | — | — |
| Q2 2022 | 2022-06-30 | 1.91 | — | — |
| Q4 2021 | 2021-12-31 | 0.04 | — | — |
Nika Pharmaceuticals current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Nika Pharmaceuticals's current ratio increased from 0.04 to 0.07, a change of 0.03. The latest reported quarter, Q2 2026, shows 0.03.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nika Pharmaceuticals source filings ↗